IFM Therapeutics Receives $27,000,000 Series A Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1922cbca-57cd-42be-b30f-c41aa4aad54f
Date
6/23/2016
Company Name
IFM Therapeutics
Mailing Address
400 Technology Square 10th Floor Cambridge, MA 02139 USA
Company Description
At IFM Therapeutics, we are driven to invent transformative therapies to improve the lives of patients with serious, life threatening diseases. We are passionate about building a company that embraces creativity, integrity, and excellence.
Website
http://www.ifmthera.com
Transaction Type
Venture Equity
Transaction Amount
$27,000,000
Transaction Round
Series A
Proceeds Purposes
The company will use the proceeds of the financing to advance and expand its early-stage portfolio and begin clinical development of its most advanced product candidate, a selective activator of a novel target, for treating solid tumors.
M&A Terms
Venture Investor
Atlas Accelerator
Venture Investor
Abingworth
Venture Investor
Novartis Venture Fund